Adicet Bio Stock Buy Hold or Sell Recommendation
| ACET Stock | USD 0.78 0.01 1.27% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Adicet Bio is 'Strong Sell'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell Adicet Bio given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for Adicet Bio, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Adicet Bio Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy Adicet Stock please use our How to Invest in Adicet Bio guide. Note, we conduct extensive research on individual companies such as Adicet and provide practical buy, sell, or hold advice based on investors' constraints. Adicet Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
Adicet |
Execute Adicet Bio Buy or Sell Advice
The Adicet recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Adicet Bio. Macroaxis does not own or have any residual interests in Adicet Bio or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Adicet Bio's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Very risky | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Quite High | Details | |
Economic Sensitivity | Almost mirrors the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Adicet Bio Trading Alerts and Improvement Suggestions
| Adicet Bio generated a negative expected return over the last 90 days | |
| Adicet Bio has some characteristics of a very speculative penny stock | |
| Adicet Bio has high historical volatility and very poor performance | |
| Adicet Bio has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (117.12 M) with profit before overhead, payroll, taxes, and interest of 24.99 M. | |
| Adicet Bio currently holds about 260.64 M in cash with (92.38 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.11, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Adicet Bio has a poor financial position based on the latest SEC disclosures | |
| Roughly 69.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from news.google.com: H.C. Wainwright maintains Neutral on Adicet Bio stock - Investing.com |
Adicet Bio current analysts advice
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Adicet analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Adicet analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Average Consensus Strong Buy
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.
Adicet Bio Returns Distribution Density
The distribution of Adicet Bio's historical returns is an attempt to chart the uncertainty of Adicet Bio's future price movements. The chart of the probability distribution of Adicet Bio daily returns describes the distribution of returns around its average expected value. We use Adicet Bio price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Adicet Bio returns is essential to provide solid investment advice for Adicet Bio.
| Mean Return | -0.27 | Value At Risk | -5.88 | Potential Upside | 6.67 | Standard Deviation | 4.18 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Adicet Bio historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Adicet Stock Institutional Investors
The Adicet Bio's institutional investors refer to entities that pool money to purchase Adicet Bio's securities or originate loans. These institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds.
| Shares | Renaissance Technologies Corp | 2024-12-31 | 916.5 K | D. E. Shaw & Co Lp | 2024-12-31 | 847.1 K | Blackrock Inc | 2024-12-31 | 811.8 K | Two Sigma Advisers, Llc | 2024-12-31 | 794 K | Geode Capital Management, Llc | 2024-12-31 | 767.5 K | Two Sigma Investments Llc | 2024-12-31 | 703.4 K | Stonepine Capital Management Llc | 2024-12-31 | 700 K | Alyeska Investment Group, L.p. | 2024-12-31 | 655.7 K | Rbf Llc | 2024-12-31 | 601.1 K | Orbimed Advisors, Llc | 2024-12-31 | 11.4 M | Tang Capital Management Llc | 2024-12-31 | 8.1 M |
Adicet Bio Cash Flow Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change In Cash | 74.0M | 188.8M | (20.0M) | (97.9M) | (100.3M) | (95.3M) | |
| Free Cash Flow | (42.5M) | (64.1M) | (61.5M) | (98.2M) | (93.5M) | (88.8M) | |
| Depreciation | 1.2M | 1.5M | 2.6M | 6.1M | 4.8M | 3.4M | |
| Other Non Cash Items | (1.0M) | 1.7M | 2.6M | 22.3M | (2.3M) | (2.4M) | |
| Capital Expenditures | 990K | 13.0M | 16.8M | 4.5M | 1.1M | 1.1M | |
| Net Income | (36.7M) | (62.0M) | (69.8M) | (142.7M) | (117.1M) | (111.3M) | |
| End Period Cash Flow | 88.9M | 277.7M | 257.7M | 159.7M | 59.4M | 83.5M |
Adicet Bio Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Adicet Bio or Health Care Providers & Services sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Adicet Bio's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Adicet stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.13 | |
β | Beta against Dow Jones | 1.06 | |
σ | Overall volatility | 4.24 | |
Ir | Information ratio | -0.03 |
Adicet Bio Volatility Alert
Adicet Bio exhibits very low volatility with skewness of 0.41 and kurtosis of 0.2. Adicet Bio is a potential penny stock. Although Adicet Bio may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Adicet Bio. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Adicet instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Adicet Bio Fundamentals Vs Peers
Comparing Adicet Bio's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Adicet Bio's direct or indirect competition across all of the common fundamentals between Adicet Bio and the related equities. This way, we can detect undervalued stocks with similar characteristics as Adicet Bio or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Adicet Bio's fundamental indicators could also be used in its relative valuation, which is a method of valuing Adicet Bio by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Adicet Bio to competition |
| Fundamentals | Adicet Bio | Peer Average |
| Return On Equity | -0.58 | -0.31 |
| Return On Asset | -0.33 | -0.14 |
| Current Valuation | (93.42 M) | 16.62 B |
| Shares Outstanding | 82.69 M | 571.82 M |
| Shares Owned By Insiders | 2.75 % | 10.09 % |
| Shares Owned By Institutions | 69.45 % | 39.21 % |
| Number Of Shares Shorted | 3.78 M | 4.71 M |
| Price To Earning | 36.84 X | 28.72 X |
| Price To Book | 0.35 X | 9.51 X |
| Price To Sales | 9.72 X | 11.42 X |
| Gross Profit | 24.99 M | 27.38 B |
| EBITDA | (127.61 M) | 3.9 B |
| Net Income | (117.12 M) | 570.98 M |
| Cash And Equivalents | 260.64 M | 2.7 B |
| Cash Per Share | 6.11 X | 5.01 X |
| Total Debt | 17.23 M | 5.32 B |
| Debt To Equity | 0.08 % | 48.70 % |
| Current Ratio | 16.10 X | 2.16 X |
| Book Value Per Share | 2.57 X | 1.93 K |
| Cash Flow From Operations | (92.38 M) | 971.22 M |
| Short Ratio | 2.76 X | 4.00 X |
| Earnings Per Share | (1.33) X | 3.12 X |
| Price To Earnings To Growth | 0.82 X | 4.89 X |
| Target Price | 6.4 | |
| Number Of Employees | 143 | 18.84 K |
| Beta | 1.62 | -0.15 |
| Market Capitalization | 64.16 M | 19.03 B |
| Total Asset | 220.22 M | 29.47 B |
| Retained Earnings | (497.89 M) | 9.33 B |
| Working Capital | 160.74 M | 1.48 B |
| Current Asset | 352.66 M | 9.34 B |
| Current Liabilities | 98.91 M | 7.9 B |
| Five Year Return | 3.23 % |
Note: Disposition of 8752 shares by Brian Harvey of Adicet Bio at 0.9218 subject to Rule 16b-3 [view details]
Adicet Bio Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Adicet . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 5498.12 | |||
| Daily Balance Of Power | (0.25) | |||
| Rate Of Daily Change | 0.99 | |||
| Day Median Price | 0.79 | |||
| Day Typical Price | 0.79 | |||
| Price Action Indicator | (0.01) | |||
| Period Momentum Indicator | (0.01) |
About Adicet Bio Buy or Sell Advice
When is the right time to buy or sell Adicet Bio? Buying financial instruments such as Adicet Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Adicet Bio in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Climate Change Thematic Idea Now
Climate Change
Large and medium sized entities that are committing to fully or partially replace some traditional services or products with renewables sources of energy in order to combat global climate change. The Climate Change theme has 32 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Climate Change Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Adicet Stock Analysis
When running Adicet Bio's price analysis, check to measure Adicet Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adicet Bio is operating at the current time. Most of Adicet Bio's value examination focuses on studying past and present price action to predict the probability of Adicet Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adicet Bio's price. Additionally, you may evaluate how the addition of Adicet Bio to your portfolios can decrease your overall portfolio volatility.